Fortgeschrittenes Melanom – Erster PD-1-Antikörper Zur Monotherapie Zugelassen
Aktuelle Dermatologie - Germany
doi 10.1055/s-0035-1564962
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 7, 2015
Authors
Unknown
Publisher
Georg Thieme Verlag KG